The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder

Psychiatry Research

Volumn 169, Issue 3, 2009, Pages 244-248

  Gustafsson, Gunnar ^a   Lira, Claudia Mallea ^a   Johansson, Jon ^a   Wisén, Anita ^a   Wohlfart, Björn ^b   Ekman, Rolf ^c   Westrin, Åsa ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Brain derived neurotrophic factor; Depression; Dexamethasone suppression test; Exercise test

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; EXERCISE; FEMALE; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; UPREGULATION;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE THERAPY; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 70349246314     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.06.030     Document Type: Article

References (28)

1. Atterhog J.H., Jonsson B., and Samuelsson R. Exercise testing in Sweden: a survey of procedures. Scandinavian Journal of Clinical and Laboratory Investigation 39 (1979) 87-92
2. Aydemir O., Deveci A., and Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Progress in Neuro-psychopharmacology & Biological Psychiatry 29 (2005) 261-265
3. Begliuomini S., Casarosa E., Pluchino N., Lenzi E., Centofanti M., Freschi L., Pieri M., Genazzani A.D., Luisi S., and Genazzani A.R. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Human Reproduction 22 (2007) 995-1002
4. Borg G.A. Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise 14 (1982) 377-381
5. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 50 (2001) 260-265
6. Dahl A.A., Dahl N.H., Bjartveit Krüger M., and Stordal E. Structured psychiatric interview for general practitioners. Manual (2002), IDANT-gruppen, Trondheim
7. Dimeo F., Bauer M., Varahram I., Proest G., and Halter U. Benefits from aerobic exercise in patients with major depression: a pilot study. British Journal of Sports Medicine 35 (2001) 114-117
8. Dunn A.L., Trivedi M.H., Kampert J.B., Clark C.G., and Chambliss H.O. Exercise treatment for depression: efficacy and dose response. American Journal of Preventive Medicine 28 (2005) 1-8
9. Garcia C., Chen M.J., Garza A.A., Cotman C.W., and Russo-Neustadt A. The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 119 (2003) 721-732
10. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., and Karege F. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 (2005) 234-238
11. Gold S.M., Schulz K.H., Hartmann S., Mladek M., Lang U.E., Hellweg R., Reer R., Braumann K.M., and Heesen C. Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. Journal of Neuroimmunology 138 (2003) 99-105
12. Hallbook F. Evolution of the vertebrate neurotrophin and Trk receptor gene families. Current opinion in Neurobiology 9 (1999) 616-621
13. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews 17 (1996) 187-205
14. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience 24 (2001) 677-736
15. Ivy A.S., Rodriguez F.G., Garcia C., Chen M.J., and Russo-Neustadt A.A. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacology, Biochemistry, and Behavior 75 (2003) 81-88
16. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research 109 (2002) 143-148
17. Mattson M.P., Maudsley S., and Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences 27 (2004) 589-594
18. Pan W., Banks W.A., Fasold M.B., Bluth J., and Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37 (1998) 1553-1561
19. Rogoz Z., Skuza G., and Legutko B. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. Journal of Physiology and Pharmacology 56 (2005) 661-671
20. Rojas Vega S., Struder H.K., Vera Wahrmann B., Schmidt A., Bloch W., and Hollmann W. Acute BDNF and cortisol response to low intensity exercise and following ramp incremental exercise to exhaustion in humans. Brain Research 1121 (2006) 59-65
21. Russo-Neustadt A.A., Beard R.C., Huang Y.M., and Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101 (2000) 305-312
22. Russo-Neustadt A., Ha T., Ramirez R., and Kesslak J.P. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behavioural Brain Research 120 (2001) 87-95
23. Schule C., Zill P., Baghai T.C., Eser D., Zwanzger P., Wenig N., Rupprecht R., and Bondy B. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 31 (2006) 1019-1025
24. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., and Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 54 (2003) 70-75
25. Wisén A.G., Ekberg K., Wohlfart B., Ekman R., Westrin Å, submitted for publication. Plasma ANP and BNP during exercise in patients with major depressive disorder and in healthy controls.
26. Wisen A.G., Farazdaghi R.G., and Wohlfart B. A novel rating scale to predict maximal exercise capacity. European Journal of Applied Physiology 87 (2002) 350-357
27. Wisen A.G., and Wohlfart B. Aerobic and functional capacity in a group of healthy women: reference values and repeatability. Clinical Physiology and Functional Imaging 24 (2004) 341-351
28. von Knorring L., Ekselius L., Ramklint M., and Malmberg K. Structured Psychiatric Interview for General Practitioners, Translated and Adapted to Swedish Conditions. SmithKline Beecham AB Pharmaceuticals (1999)